KURA Kura Oncology, Inc.: institutional ownership and insider trading
233 funds reported holding $1.02B of Kura Oncology, Inc. in their latest 13F filings; in Q2 2026 funds net bought $30.0M, with 26 new positions and 26 funds selling out; over the last 12 months insiders bought $2.35M and sold $3.84M on the open market.
Famous investors holding KURA
- Renaissance Technologies (Renaissance Technologies): $18.3M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $7.80M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.84M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.84M, 0.0% of the portfolio
Largest institutional holders of KURA
- BlackRock, Inc. (BLK) — $115M
- SUVRETTA CAPITAL MANAGEMENT, LLC — $94.1M
- BVF INC/IL — $92.7M
- STATE STREET CORP (STT, STT-PG) — $58.5M
- VANGUARD GROUP INC — $57.2M
- VANGUARD CAPITAL MANAGEMENT LLC — $43.0M
- ARMISTICE CAPITAL, LLC — $40.3M
- AQR CAPITAL MANAGEMENT LLC — $34.3M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $24.8M
- GEODE CAPITAL MANAGEMENT, LLC — $24.5M
Recent KURA insider trades
- Sep 29, 2026: Powl Brian T. sold 32,450 shares ($345K)
- Sep 29, 2026: Leoni Mollie sold 41,250 shares ($440K)
- Sep 29, 2026: Ford Kathleen sold 10,574 shares ($112K)
- Sep 28, 2026: Doyle Thomas James sold 4,607 shares ($48.4K)
5%+ owners
- Montanova Capital, LLC: 9.7% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Apr 30, 2026)